- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery and development of varenicline for smoking cessation
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 13, Issue 7, Pages 671-683
Publisher
Informa UK Limited
Online
2018-03-28
DOI
10.1080/17460441.2018.1458090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction
- (2018) Alan J. Cross et al. BIOLOGICAL PSYCHIATRY
- Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment
- (2017) Paul M. Cinciripini et al. PSYCHOPHARMACOLOGY
- Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo
- (2017) Rae A. Littlewood et al. PSYCHOPHARMACOLOGY
- Sensitive periods of substance abuse: Early risk for the transition to dependence
- (2017) Chloe J. Jordan et al. Developmental Cognitive Neuroscience
- Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers
- (2017) Elise Lesage et al. JAMA Psychiatry
- A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
- (2017) Ali Ramazan Benli et al. Tobacco Induced Diseases
- Getting cytisine licensed for use world-wide: a call to action
- (2016) Natalie Walker et al. ADDICTION
- Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse
- (2016) D. Funk et al. BEHAVIOURAL BRAIN RESEARCH
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
- (2016) Robert M Anthenelli et al. LANCET
- Varenicline for Smoking Cessation in Light Smokers
- (2016) Jon O. Ebbert et al. NICOTINE & TOBACCO RESEARCH
- Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats
- (2016) Xia Li et al. PSYCHOPHARMACOLOGY
- The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice
- (2016) Fernando B. de Moura et al. PSYCHOPHARMACOLOGY
- The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys
- (2015) Zuzana Justinova et al. BIOLOGICAL PSYCHIATRY
- Agonist and antagonist effects of cytisine in vivo
- (2015) Elena V. Radchenko et al. NEUROPHARMACOLOGY
- Chronic treatment with varenicline changes expression of four nAChR binding sites in mice
- (2015) Michael J. Marks et al. NEUROPHARMACOLOGY
- Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys
- (2015) Zuzana Justinova et al. PSYCHOPHARMACOLOGY
- Evaluation of the cardiovascular effects of varenicline in rats
- (2015) Engin Burak Selcuk et al. Drug Design Development and Therapy
- Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation
- (2014) Josep M Ramon et al. BMC Medicine
- Pharmacokinetics of cytisine, an α4β2nicotinic receptor partial agonist, in healthy smokers following a single dose
- (2014) Soo Hee Jeong et al. Drug Testing and Analysis
- Comparison of the Reinforcing Properties of Nicotine and Cigarette Smoke Extract in Rats
- (2014) Matthew R Costello et al. NEUROPSYCHOPHARMACOLOGY
- Cytisine versus Nicotine for Smoking Cessation
- (2014) Natalie Walker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concurrent access to nicotine and sucrose in rats
- (2014) Leigh V. Panlilio et al. PSYCHOPHARMACOLOGY
- Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline
- (2014) Rachel L. Schassburger et al. PSYCHOPHARMACOLOGY
- The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats
- (2013) Wouter Goutier et al. ADDICTION BIOLOGY
- The current development of CNS drug research
- (2013) Gregers Wegener et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effects of Chronic Varenicline Treatment on Nicotine, Cocaine and Concurrent Nicotine+Cocaine Self-Administration
- (2013) Nancy K Mello et al. NEUROPSYCHOPHARMACOLOGY
- Varenicline and Cytisine Diminish the Dysphoric-Like State Associated with Spontaneous Nicotine Withdrawal in Rats
- (2013) Moe Igari et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis
- (2013) Peter Hajek et al. THORAX
- Cytisine, the world's oldest smoking cessation aid
- (2013) J. J. Prochaska et al. BMJ-British Medical Journal
- Resisting the Urge to Smoke and Craving during a Smoking Quit Attempt on Varenicline: Results from a Pilot FMRI Study
- (2013) Karen J. Hartwell et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Effects of Varenicline and Bupropion Sustained-Release Use Plus Intensive Smoking Cessation Counseling on Prolonged Abstinence From Smoking and on Depression, Negative Affect, and Other Symptoms of Nicotine Withdrawal
- (2013) Paul M. Cinciripini et al. JAMA Psychiatry
- Presynaptic 4 2 Nicotinic Acetylcholine Receptors Increase Glutamate Release and Serotonin Neuron Excitability in the Dorsal Raphe Nucleus
- (2012) J. Garduno et al. JOURNAL OF NEUROSCIENCE
- Effects of Varenicline on Smoking Cue–Triggered Neural and Craving Responses
- (2011) Teresa Franklin et al. ARCHIVES OF GENERAL PSYCHIATRY
- Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used
- (2011) Bernard Le Foll et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Metabotropic Glutamate 2/3 Receptor Agonist LY379268 Blocked Nicotine-Induced Increases in Nucleus Accumbens Shell Dopamine only in the Presence of a Nicotine-Associated Context in Rats
- (2011) Manoranjan S D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Placebo-Controlled Trial of Cytisine for Smoking Cessation
- (2011) Robert West et al. NEW ENGLAND JOURNAL OF MEDICINE
- Varenicline Dose Dependently Enhances Responding for Nonpharmacological Reinforcers and Attenuates the Reinforcement-Enhancing Effects of Nicotine
- (2011) M. E. Levin et al. NICOTINE & TOBACCO RESEARCH
- Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal
- (2011) Astrid K. Stoker et al. PSYCHOPHARMACOLOGY
- Effects of the α4β2 Partial Agonist Varenicline on Brain Activity and Working Memory in Abstinent Smokers
- (2010) James Loughead et al. BIOLOGICAL PSYCHIATRY
- Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease
- (2010) Nancy A. Rigotti et al. CIRCULATION
- Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats
- (2010) Grazyna Biala et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory
- (2010) Satoshi Ikemoto NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Parallel Anxiolytic-Like Effects and Upregulation of Neuronal Nicotinic Acetylcholine Receptors Following Chronic Nicotine and Varenicline
- (2010) J. R. Turner et al. NICOTINE & TOBACCO RESEARCH
- Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice
- (2010) Grazyna Biala et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats
- (2010) Neil E. Paterson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Mechanism-based medication development for the treatment of nicotine dependence
- (2009) Zheng-xiong Xi et al. ACTA PHARMACOLOGICA SINICA
- Varenicline: A first-line treatment option for smoking cessation
- (2009) Gina Daubney Garrison et al. CLINICAL THERAPEUTICS
- Dopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum Exploited by Nicotine
- (2009) T. Zhang et al. JOURNAL OF NEUROSCIENCE
- Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats
- (2009) Krista Spiller et al. NEUROPHARMACOLOGY
- The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
- (2009) Eoin C. O’Connor et al. PSYCHOPHARMACOLOGY
- Smoking Cessation Rates in the United States: A Comparison of Young Adult and Older Smokers
- (2008) Karen Messer et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics
- (2008) Neal L. Benowitz Annual Review of Pharmacology and Toxicology
- The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial
- (2008) Raymond Niaura et al. CURRENT MEDICAL RESEARCH AND OPINION
- Crucial Role of 4 and 6 Nicotinic Acetylcholine Receptor Subunits from Ventral Tegmental Area in Systemic Nicotine Self-Administration
- (2008) S. Pons et al. JOURNAL OF NEUROSCIENCE
- Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
- (2008) H-J Aubin et al. THORAX
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now